Doxylamine succinate clinical trials
A product of Doxylamine; its studies count on that page too.
How each study uses doxylamine succinate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 7 Apr 1948 · DECAPRYN · NDA 006412 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2019 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Bahria University (1) · Duchesnay Inc. (1) · Grünenthal GmbH (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Doxylamine
- One of Antihistamines source
- One of Histamine H1 Antagonists source
Studies
Open first, then newest update. How each study uses doxylamine succinate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Date Fruit Benefits to Treat Morning Sickness in First Trimester of PregnancyActive, not recruitingNot applicableBahria UniversityNCT07354529Written as Doxylamine succinate 10 mg + Pyridoxine HCl 10 mgHow we know
- The Efficacy Of Diclectin® For Nausea And Vomiting Of PregnancyCompletedPhase 3Duchesnay Inc.NCT00614445Written as doxylamine succinate 10 mg/pyridoxine hydrochloride 10 mgHow we know
- A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting ConditionsWithdrawnPhase 1Grünenthal GmbHNCT03905564Written as doxylamine succinate 10 mg/pyridoxine hydrochloride 10 mg combinationHow we know
Codes
What other systems call doxylamine succinate · ClinicalTrials.gg INT003049
- MeSH (NLM) C035385doxylamine succinateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) V9BI9B5YI2DOXYLAMINE SUCCINATEConfirmed FDA, NLM, Wikidata
- RxNorm 23665One source FDA
- Wikidata Q72470509Doxylamine succinateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47501Doxylamine SuccinateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C035385 | doxylamine succinate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | V9BI9B5YI2 | DOXYLAMINE SUCCINATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 23665 | — | One source FDA |
| Wikidata | Q72470509 | Doxylamine succinate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47501 | Doxylamine Succinate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.